- Home
- TASK vs PLSE Comparison
TASK vs PLSE Comparison
Compare TASK & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TASK | PLSE |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TASK | PLSE |
|---|---|---|
| Price | $11.48 | $14.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $17.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 257.0K | 183.4K |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.76 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $1,144,833,000.00 | $86,000.00 |
| Revenue This Year | $20.40 | N/A |
| Revenue Next Year | $7.85 | $1,002.94 |
| P/E Ratio | $13.04 | ★ N/A |
| Revenue Growth | ★ 19.88 | N/A |
| 52 Week Low | $10.68 | $12.56 |
| 52 Week High | $18.59 | $25.00 |
Technical Indicators
Market Signals| Indicator | TASK | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 55.35 |
| Support Level | $11.36 | $14.33 |
| Resistance Level | $11.68 | $15.96 |
| Average True Range (ATR) | 0.34 | 0.73 |
| MACD | 0.00 | 0.23 |
| Stochastic Oscillator | 14.60 | 61.27 |
Price Performance
Historical ComparisonAbout TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world-wide Game-changing companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.